ArticleEFSA journal. European Food Safety Authority2026
Assessment of genetically modified soybean DAS-44406 × FG72 (dossier GMFF-2025-34192).
Article in EFSA journal. European Food Safety Authority, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
29 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Genetically modified soybean DAS-44406-6 × FG72 was developed by conventional crossing to combine two single events: DAS-44406-6 and FG72. The soybean DAS-44406-6 × FG72 expresses the AAD-12, 2mEPSPS, PAT and HPPD W336 proteins to confer herbicide tolerance to 2,4-D-, glyphosate-, glufosinate-containing and HPPD-inhibiting herbicide products, respectively. The GMO Panel previously assessed the two single soybean events and did not identify safety concerns. No new data on the single soybean events were identified that could lead to modification of the original conclusions on their safety. The molecular characterisation, comparative analysis (agronomic, phenotypic and compositional characteristics) and the outcome of the toxicological, allergenicity and nutritional assessment indicate that the combination of the single soybean events and of the newly expressed proteins in the soybean DAS-44406-6 × FG72 does not give rise to food and feed safety or nutritional concerns. The GMO Panel concludes that the DAS-44406-6 × FG72 stack soybean, as described in this application, is as safe as the non-GM comparator and non-GM reference varieties tested, and no post-market monitoring of food and feed is considered necessary. In the case of release of processed soybean DAS-44406-6 × FG72 or accidental spillage of viable GM soybean seeds into the environment, this would not raise environmental safety concerns. The post market environmental monitoring plan and reporting intervals are in line with the intended uses of soybean DAS-44406-6 × FG72. The GMO Panel concludes that soybean DAS-44406-6 × FG72 is as safe as its non-GM comparator and the tested non-GM reference varieties with respect to potential effects on human and animal health and the environment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.